Venetoclax, Rituximab and Nivolumab in Combination for the Treatment of Richter's Transformation Arising From Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Name: Venetoclax, Rituximab and Nivolumab in Combination for the Treatment of Richter's Transformation Arising From Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
License: Public Domain

Northwestern University

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

recurrent transformed chronic lymphocytic leukemia, refractory transformed chronic lymphocytic leukemia, richter syndrome, transformed chronic lymphocytic leukemia to diffuse large b-cell lymphoma, transformed small lymphocytic lymphoma to diffuse large b-cell lymphoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 417544
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.